Viral load of human papillomavirus and risk of CIN3 or cervical cancer
Authors:
- Attila T LorinczALAttila T Lorincz
- Philip E CastlePCPhilip E Castle
- Mark E ShermanMSMark E Sherman
- David R ScottDSDavid R Scott
- Andrew G GlassAGAndrew G Glass
- Sholom WacholderSWSholom Wacholder
- Brenda B RushBRBrenda B Rush
- Patti E GravittPGPatti E Gravitt
- John E SchusslerJSJohn E Schussler
- Mark SchiffmanMSMark Schiffman
- 1 July 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 360 (9328) , 228-229
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United KingdomCancer, 2002
- Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control studyThe Lancet, 2000
- HPV DNA Testing in Cervical Cancer ScreeningJAMA, 2000
- Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial NeoplasiaJNCI: Journal of the National Cancer Institute, 1993
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993